Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Post Marketing Non Interventional Study to Evaluate the Criteria on Which Renewal of LHRH Analogue Treatment is Made in Patients With Prostate Cancer Locally Advanced or Metastatic.

NCT03017313 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT03017313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03017313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Post Marketing Non Interventional Study to Evaluate the Criteria on Which Renewal of LHRH Analogue Treatment is Made in Patients With Prostate Cancer Locally Advanced or Metastatic.
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
July 13, 2017
Completion date
June 14, 2021
Enrollment
510 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer